|
|
|
|
|
|
||
|
|
||||
|
|
||||
|
||||
Tumor Biology |
The Arthur and Sonia Labatt Brain Tumour Research Centre, Hospital for Sick Children, Toronto, Ontario, Canada (S.A.W., C.J.M., A.G.); and Department of Medical Biophysics (S.A.W., C.J.M., A.G.) and Division of Neurosurgery (A.G.), University of Toronto, Toronto, Ontario, Canada
2 Address correspondence and reprint requests to Abhijit Guha, 4W-446, Western Hospital, 399 Bathurst St., Toronto, Ontario, Canada, M5T 2S8.
Abstract
Malignant astrocytomas are characterized by extensive vascularization attributed to increased expression of the angiogenic cytokine vascular endothelial growth factor (VEGF). VEGF is elevated in astrocytomas under normal oxygen conditions and undergoes induction in hypoxic stress. Prior studies have shown that both the phosphatidylinositol 3-kinase (PI3-kinase) and MEK1/2 (MAPK/ERK kinase 1/2) pathways promote proliferation of astrocytoma cells and growth of astrocytic tumors. Whether these pathways regulate growth by modulating angiogenesis as well as proliferation is not clear. In this study, pharmacologic inhibitors were used to specifically inhibit PI3-kinase and MEK1/2 activity in human malignant astrocytoma cell lines, and their effects on VEGF expression were determined. Northern blot analysis of VEGF messenger RNA (mRNA) from cells treated with inhibitors demonstrated cell line-specific responses. The PI3-kinase pathway regulated both the normoxic expression and hypoxic induction of VEGF in 2 cell lines, whereas MEK1/2 regulated only the normoxic expression in the same 2 lines. The third cell line showed no change in VEGF mRNA with inhibition of either of these 2 pathways. This study suggests that modulation of signaling pathways implicated in proliferation of astrocytoma cell lines may have varying effects in vivo depending on the role these pathways play in regulating tumor angiogenesis.
References
Bouterfa, H.L., Sattelmeyer, V., Czub, S., Vordermark, D., Roosen, K., and Tonn, J.C. (2000) Inhibition of Ras farnesylation by lovastatin leads to downregulation of proliferation and migration in primary cultured human glioblastoma cells. Anticancer Res. 20,2761 -2771.[ISI][Medline]
Damert, A., Ikeda, E., and Risau, W. (1997) Activator-protein-1 binding potentiates the hypoxia-induciblefactor-1–mediated hypoxia-induced transcriptional activation of vascular-endothelial growth factor expression in C6 glioma cells. Biochem. J., 327,419 -423.
Feldkamp, M., Lau, N., Roncari, L., and Guha, A.
(2001) Isotype-specific Ras.GTP-levels predict the efficacy of
farnesyl transferase inhibitors against human astrocytomas regardless of Ras
mutational status. Cancer Res.
61,4425
-4431.
Feldkamp, M.M., Lau, N., and Guha, A. (1999a) The farnesyltransferase inhibitor L-744,832 inhibits the growth of astrocytomas through a combination of antiproliferative, antiangiogenic, and proapoptotic activities. Ann. N.Y. Acad. Sci. 886,257 -260.[CrossRef][ISI][Medline]
Feldkamp, M.M., Lau, N., and Guha, A. (1999b) Growth inhibition of astrocytoma cells by farnesyl transferase inhibitors is mediated by a combination of anti-proliferative, pro-apoptotic and anti-angiogenic effects. Oncogene 18,7514 -7526.[CrossRef][ISI][Medline]
Feldkamp, M.M., Lau, N., Rak, J., Kerbel, R.S., and Guha, A. (1999c) Normoxic and hypoxic regulation of vascular endothelial growth factor (VEGF) by astrocytoma cells is mediated by Ras. Int. J. Cancer 81,118 -124.[CrossRef][ISI][Medline]
Finkenzeller, G., Sparacio, A., Technau, A., Marme, D., and Siemeister, G. (1997) Sp1 recognition sites in the proximal promoter of the human vascular endothelial growth factor gene are essential for platelet-derived growth factor-induced gene expression. Oncogene 15,669 -676.[CrossRef][ISI][Medline]
Finkenzeller, G., Technau, A., and Marme, D. (1995) Hypoxia-induced transcription of the vascular endothelial growth factor gene is independent of functional AP-1 transcription factor. Biochem. Biophys. Res. Commun. 208,432 -439.[CrossRef][ISI][Medline]
Forsythe, J.A., Jiang, B.H., Iyer, N.V., Agani, F., Leung, S.W., Koos, R.D., and Semenza, G.L. (1996) Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1. Mol. Cell Biol. 16,4604 -4613.[Abstract]
Grugel, S., Finkenzeller, G., Weindel, K., Barleon, B., and Marme,
D. (1995) Both v-Ha-Ras and v-Raf stimulate expression of the
vascular endothelial growth factor in NIH 3T3 cells. J. Biol.
Chem. 270,25915
-25919.
Guha, A., Feldkamp, M.M., Lau, N., Boss, G., and Pawson, A. (1997) Proliferation of human malignant astrocytomas is dependent on Ras activation. Oncogene 15,2755 -2765.[CrossRef][ISI][Medline]
Hashimoto, E., Ogita, T., Nakaoka, T., Matsuoka, R., Takao, A., and Kira, Y. (1994) Rapid induction of vascular endothelial growth factor expression by transient ischemia in rat heart. Am. J. Physiol. 267,H1948 -H1954.
Horiuchi, T., and Weller, P.F. (1997) Expression of
vascular endothelial growth factor by human eosinophils: Upregulation by
granulocyte macrophage colony-stimulating factor and interleukin-5.
Am. J. Respir. Cell Mol. Biol.
17, 70-77.
Jiang, B.H., Zheng, J.Z., Aoki, M., and Vogt, P.K.
(2000) Phosphatidylinositol 3–kinase signaling mediates
angiogenesis and expression of vascular endothelial growth factor in
endothelial cells. Proc. Natl. Acad. Sci. U.S.A.
97,1749
-1753.
Jung, Y.D., Nakano, K., Liu, W., Gallick, G.E., and Ellis, L.M.
(1999) Extracellular signal-regulated kinase activation is
required for up-regulation of vascular endothelial growth factor by serum
starvation in human colon carcinoma cells. Cancer Res.
59,4804
-4807.
Ladoux, A., and Frelin, C. (1993) Hypoxia is a strong inducer of vascular endothelial growth factor mRNA expression in the heart. Biochem. Biophys. Res. Commun. 195,1005 -1010.[CrossRef][ISI][Medline]
Larcher, F., Robles, A.I., Duran, H., Murillas, R., Quintanilla,
M., Cano, A., Conti, C.J., and Jorcano, J.L. (1996) Up-regulation
of vascular endothelial growth factor/vascular permeability factor in mouse
skin carcinogenesis correlates with malignant progression state and activated
H-ras expression levels. Cancer Res.
56,5391
-5396.
Levy, A.P., Levy, N.S., and Goldberg, M.A. (1996)
Post-transcriptional regulation of vascular endothelial growth factor by
hypoxia. J. Biol. Chem.
271,2746
-2753.
Mahaley, M.S., Jr., Mettlin, C., Natarajan, N., Laws, E.R., Jr., and Peace, B.B. (1989) National survey of patterns of care for brain-tumor patients. J. Neurosurg. 71,826 -836.[ISI][Medline]
Maity, A., Pore, N., Lee, J., Solomon, D., and O'Rourke, D.
(2000) Epidermal growth factor receptor transcriptionally
up-regulates vascular endothelial growth factor expression in human
glioblastoma cells via a pathway involving phosphatidylinositol 3'-kinase and
distinct from that induced by hypoxia. Cancer Res.
60,5879
-5886.
Mazure, N.M., Chen, E.Y., Laderoute, K.R., and Giaccia, A.J.
(1997) Induction of vascular endothelial growth factor by hypoxia
is modulated by a phosphatidylinositol 3–kinase/Akt signaling pathway in
Ha-ras-transformed cells through a hypoxia inducible factor-1 transcriptional
element. Blood 90,3322
-3331.
Mazure, N.M., Chen, E.Y., Yeh, P., Laderoute, K.R., and Giaccia,
A.J. (1996) Oncogenic transformation and hypoxia synergistically
act to modulate vascular endothelial growth factor expression.
Cancer Res. 56,3436
-3440.
Milanini, J., Vinals, F., Pouyssegur, J., and Pages, G.
(1998) p42/p44 MAP kinase module plays a key role in the
transcriptional regulation of the vascular endothelial growth factor gene in
fibroblasts. J. Biol. Chem.
273,18165
-18172.
Minet, E., Arnould, T., Michel, G., Roland, I., Mottet, D., Raes, M., Remacle, J., and Michiels, C. (2000) ERK activation upon hypoxia: Involvement in HIF-1 activation. FEBS Lett. 468, 53-58.[CrossRef][ISI][Medline]
Pages, G., Milanini, J., Richard, D.E., Berra, E., Gothie, E., Vinals, F., and Pouyssegur, J. (2000) Signaling angiogenesis via p42/p44 MAP kinase cascade. Ann. N.Y. Acad. Sci. 902,187 -200.[CrossRef][ISI][Medline]
Rak, J., Mitsuhashi, Y., Sheehan, C., Tamir, A., Viloria-Petit, A.,
Filmus, J., Mansour, S.J., Ahn, N.G., and Kerbel, R.S. (2000)
Oncogenes and tumor angiogenesis: Differential modes of vascular endothelial
growth factor up-regulation in ras-transformed epithelial cells and
fibroblasts. Cancer Res.
60,490
-498.
Richard, D.E., Berra, E., Gothie, E., Roux, D., and Pouyssegur, J.
(1999) p42/p44 mitogen-activated protein kinases phosphorylate
hypoxiainducible factor 1alpha (HIF-1alpha) and enhance the transcriptional
activity of HIF-1. J. Biol. Chem.
274,32631
-32637.
Ryuto, M., Ono, M., Izumi, H., Yoshida, S., Weich, H.A., Kohno, K.,
and Kuwano, M. (1996) Induction of vascular endothelial growth
factor by tumor necrosis factor alpha in human glioma cells: Possible roles of
SP-1. J. Biol. Chem.
271,28220
-28228.
Sheta, E.A., Harding, M.A., Conaway, M.R., and Theodorescu, D.
(2000) Focal adhesion kinase, Rap1, and transcriptional induction
of vascular endothelial growth factor. J. Natl. Cancer
Inst. 92,1065
-1073.
Tsai, J.C., Goldman, C.K., and Gillespie, G.Y. (1995) Vascular endothelial growth factor in human glioma cell lines: Induced secretion by EGF, PDGFBB, and bFGF. J. Neurosurg. 82,864 -873.[ISI][Medline]
Wang, D., Huang, H.J., Kazlauskas, A., and Cavenee, W.K.
(1999) Induction of vascular endothelial growth factor expression
in endothelial cells by platelet-derived growth factor through the activation
of phosphatidylinositol 3–kinase. Cancer Res.
59,1464
-1472.
Wang, G.L., Jiang, B.H., Rue, E.A., and Semenza, G.L.
(1995) Hypoxiainducible factor 1 is a basic-helix-loop-helix-PAS
heterodimer regulated by cellular O2 tension. Proc. Natl. Acad.
Sci. U.S.A. 92,5510
-5514.
Wang, G.L., and Semenza, G.L. (1993) Characterization
of hypoxia-inducible factor 1 and regulation of DNA binding activity by
hypoxia. J. Biol. Chem.
268,21513
-21518.
Warren, R.S., Yuan, H., Matli, M.R., Ferrara, N., and Donner, D.B.
(1996) Induction of vascular endothelial growth factor by
insulin-like growth factor 1 in colorectal carcinoma. J. Biol.
Chem. 271,29483
-29488.
White, F.C., Benehacene, A., Scheele, J.S., and Kamps, M. (1997) VEGF mRNA is stabilized by ras and tyrosine kinase oncogenes, as well as by UV radiation—evidence for divergent stabilization pathways. Growth Factors 14,199 -212.[ISI][Medline]
Wood, S.M., Gleadle, J.M., Pugh, C.W., Hankinson, O., and
Ratcliffe, P.J. (1996) The role of the aryl hydrocarbon receptor
nuclear translocator (ARNT) in hypoxic induction of gene expression: Studies
in ARNT-deficient cells. J. Biol. Chem.
271,15117
-15123.
Zhong, H., Chiles, K., Feldser, D., Laughner, E., Hanrahan, C.,
Georgescu, M.M., Simons, J.W., and Semenza, G.L. (2000)
Modulation of hypoxiainducible factor 1alpha expression by the epidermal
growth factor/phosphatidylinositol 3–kinase/PTEN/AKT/FRAP pathway in
human prostate cancer cells: Implications for tumor angiogenesis and
therapeutics. Cancer Res.
60,1541
-1545.
Zundel, W., Schindler, C., Haas-Kogan, D., Koong, A., Kaper, F.,
Chen, E., Gottschalk, A.R., Ryan, H.E., Johnson, R.S., Jefferson, A.B.,
Stokoe, D., and Giaccia, A.J. (2000) Loss of PTEN facilitates
H1F-1–mediated gene expression. Genes Dev.
14,391
-396.
This article has been cited by other articles:
|
|
 |
|
  N. Pore, Z. Jiang, H.-K. Shu, E. Bernhard, G. D. Kao, and A. Maity Akt1 Activation Can Augment Hypoxia-Inducible Factor-1{alpha} Expression by Increasing Protein Translation through a Mammalian Target of Rapamycin-Independent Pathway Mol. Cancer Res., July 1, 2006; 4(7): 471 - 479. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Blum, J. Jacob-Hirsch, N. Amariglio, G. Rechavi, and Y. Kloog Ras Inhibition in Glioblastoma Down-regulates Hypoxia-Inducible Factor-1{alpha}, Causing Glycolysis Shutdown and Cell Death Cancer Res., February 1, 2005; 65(3): 999 - 1006. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Pore, S. Liu, H.-K. Shu, B. Li, D. Haas-Kogan, D. Stokoe, J. Milanini-Mongiat, G. Pages, D. M. O'Rourke, E. Bernhard, et al. Sp1 Is Involved in Akt-mediated Induction of VEGF Expression through an HIF-1-independent Mechanism Mol. Biol. Cell, November 1, 2004; 15(11): 4841 - 4853. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Neid, K. Datta, S. Stephan, I. Khanna, S. Pal, L. Shaw, M. White, and D. Mukhopadhyay Role of Insulin Receptor Substrates and Protein Kinase C-{zeta} in Vascular Permeability Factor/Vascular Endothelial Growth Factor Expression in Pancreatic Cancer Cells J. Biol. Chem., February 6, 2004; 279(6): 3941 - 3948. [Abstract] [Full Text] [PDF]
|
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|
